Henry Uppal

Bachelor of Medicine and Bachelor of Science,  Massachusetts General Hospital 

Location: Germany

Consulting Services

IT-Web-Mobile Technology Data Science-Bioinformatics

Areas Of Interest

Spaces, Intracellular Junction, Intercellular Artery, Bronchial Lower Esophageal Sphincter Meningioma, Hemangioblastic Nephrosis Translational Initiation, Protein Pemoline Magnesium Job related Stress Genetic Non-Disjunctions Racemases Dehydrogenase, Decanoyl CoA Vulva Cancer Phosphofructokinase-1, Muscle Type beta Endosulfan Urisan Necrotizing Lymphadenitis, Kikuchi Acemuc Nuclear Receptor Co-Repressor 2 Gene Products, ras Potassium Channels, Sodium Activated Regions, Ig Constant Management, Anger Indium-DTPA Carcinoma, Non Small Cell Lung WD40 Repeats Cooperative Behaviors

Professional Narrative

Dr. Henry Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Mayo Clinic 1994
Senior Director, Mayo Clinic 1999

Education

Doctor of medicine, Harvard Medical School 1993
Master of Science in physician assistant, Perelman School of Medicine 2016

Referees


Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :